Lymph node metastasis of 3 (15.8%), 2 (10.5%) and 2 (10.5%) patients exhibited amplifications in all 3 exons of ERBB2, CCND1 and MYC, respectively. This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.